Acute Epstein-Barr virus-related myocarditis: life-threatening complication in immunocompetent patient

Authors

  • Darpan P. Kothia Department of Medicine, Shri M.P. Shah Medical College, Jamnagar, Gujarat, India
  • Priyanka J. Rabadia Department of Pediatrics, Shri M.P. Shah Medical College, Jamnagar, Gujarat, India
  • Bhaumikkumar M. Patel Shri M.P. Shah Medical College, Jamnagar, Gujarat, India
  • Prakash V. Makwana Department of Medicine, Shri M.P. Shah Medical College, Jamnagar, Gujarat, India

DOI:

https://doi.org/10.18203/2320-6012.ijrms20242244

Keywords:

Epstein-Barr virus, Myocarditis, Dengue-mimic

Abstract

Acute Epstein-Barr virus (EBV) related myocarditis is an uncommon but potentially life-threatening condition, particularly in immunocompetent individuals. We present a case of a 14-year-old male with no prior medical history who presented with high-grade fever, sore throat, and dyspnea on exertion. Laboratory tests and echocardiography confirmed the diagnosis of myocarditis secondary to EBV infection. The patient required conservative treatment. Follow-up at post-discharge revealed complete recovery, with normal echocardiographic findings and no residual symptoms. This case underscores the importance of early recognition and intervention in EBV-related myocarditis. Despite its rarity, clinicians should consider viral myocarditis in patients with systemic EBV infection and cardiac symptoms. Aggressive supportive care can lead to full recovery, as demonstrated by this case. It can present as a dengue-mimic.

Metrics

Metrics Loading ...

References

Mason JW, O'Connell JB, Herskowitz A, Rose NR, McManus BM, Billingham ME, et al. A clinical trial of immunosuppressive therapy for myocarditis. The Myocarditis Treatment Trial Investigators. N Engl J Med. 1995;333(5):269-75.

Drory Y, Turetz Y, Hiss Y, Lev B, Fisman EZ, Pines A, et al. Sudden unexpected death caused by myocarditis. Harefuah. 1991;120(6):306-8.

Maisch B, Pankuweit S. Current Treatment Options in Myocarditis. Dtsch Arztebl Int. 2012;109(31-32):505-11.

Esfandiarei M, McManus BM. Viral Myocarditis: Incidence, Diagnosis, and Clinical Management. Heart Fail Clin. 2008;4(4):307-19.

Blauwet LA, Cooper LT. Myocarditis. Prog Cardiovasc Dis. 2010;52(4):274-88.

Kühl U, Schultheiss HP. Viral myocarditis. Swiss Med Wkly. 2009;139(35-36):438-45.

Shioji K, Kishimoto C, Komiyama T, Yamaguchi H, Hayashi T, Takayama M, et al. Acute Myocarditis Associated with Epstein-Barr Virus Infection. Jpn Circ J. 2004;65(6):539-42.

Magnani JW, Dec GW. Myocarditis: Current Trends in Diagnosis and Treatment. Circulation. 2006;113(6):876-90.

Hufnagel G, Pankuweit S, Richter A, Schönian U, Maisch B. The European Study of Epidemiology and Treatment of Cardiac Inflammatory Diseases (ESETCID). First Epidemiological Results. Herz. 2021;46(4):330-6.

Caforio ALP, Pankuweit S, Arbustini E, Basso C, Gimeno-Blanes J, Felix SB, et al. Current state of knowledge on aetiology, diagnosis, management, and therapy of myocarditis: a position statement of the ESC Working Group on Myocardial and Pericardial Diseases. Eur Heart J. 2013;34(33):2636-48.

Downloads

Published

2024-07-31

How to Cite

Kothia, D. P., Rabadia, P. J., Patel, B. M., & Makwana, P. V. (2024). Acute Epstein-Barr virus-related myocarditis: life-threatening complication in immunocompetent patient. International Journal of Research in Medical Sciences, 12(8), 3050–3053. https://doi.org/10.18203/2320-6012.ijrms20242244

Issue

Section

Case Reports